Institutional Ownership
Cumberland Pharmaceuticals I
CUSIP 230770109COMCPIXQ1 2026
Institutional Holders
27
13F filers
Shares Held
2.35M
Aggregate institutional
Institutional Value
$7.51M
Q1 2026
Net New Holders
+1
7 new · 6 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions7
Increased5
Decreased9
Sold out6
Institutional Holders
27 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Ikarian Capital, LLC | 553.2K | $1.80M | −2.8K | Reduced |
| 2 | Renaissance Technologies LLC | 470.7K | $1.53M | −1.5K | Reduced |
| 3 | Dimensional Fund Advisors LP | 276.4K | $898.2K | +4.1K | Added |
| 4 | Perceptive Advisors LLC | 197.0K | $640.2K | −144.1K | Reduced |
| 5 | Bridgeway Capital Management, LLC | 163.5K | $531.3K | 0 | Held |
| 6 | Boothbay Fund Management, LLC | 127.7K | $415.0K | −813 | Reduced |
| 7 | Geode Capital Management, LLC | 114.3K | $371.5K | +7.0K | Added |
| 8 | J. Goldman & Co LP | 81.0K | $263.4K | −13.5K | Reduced |
| 9 | Bank Of New York Mellon Corp | 58.5K | $190.0K | −14.1K | Reduced |
| 10 | Blackrock, Inc. | 56.9K | $184.9K | +4.3K | Added |
17 more institutional holders on Premium
See every fund holding Cumberland Pharmaceuticals I, with full quarter-over-quarter share changes.
Unlock all holders